Universitätsmedizin der Johannes Gutenberg Universität Mainz

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
The "Global Paradise System" Registry	cardiovascular disorder, hypertensive disorder, vascular disorder	Recruiting	Not stated	2026-06-04	NCT05027685
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-06-01	NCT03900429
The European NAFLD Registry	Body Weight, Digestive System Diseases, Digestive System Neoplasms, Dyslipidemias, Fibrosis, Fibrosis, Liver, Lipid Metabolism Disorders, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, adenocarcinoma, carcinoma, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, epithelial neoplasm, fatty liver disease, glucose metabolism disease, hepatocellular carcinoma, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, neoplasm, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder	Recruiting	Not stated	2023-01-06	NCT04442334

Clinical trials